Author:
Gunasekaran Vinoth Prasanna,Naidu Sudarshan,Nishi Kumari
Reference55 articles.
1. Adhami VM, Khan MI, Lall RK, Siddiqui IA, Syed DN, Sechi M, Dodwad SJ, Mukhtar H (2013) Role of YB-1, a regulator of epithelial to mesenchymal transition, in prostate cancer: inhibition by a dietary flavonoid fisetin. Cancer Res 73:5551
2. Anjum R, Blenis J (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9(10):747–758
3. Bader AG, Vogt PK (2008) Phosphorylation by Akt disables the anti-oncogenic activity of YB-1. Oncogene 27(8):1179–1182
4. Basaki Y, Hosoi F, Oda Y, Fotovati A, Maruyama Y, Oie S, Ono M, Izumi H, Kohno K, Sakai K, Shimoyama T (2007) Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 26:2736–2746
5. Bergmann S, Royer-Pokora B, Fietze E, Jürchott K, Hildebrandt B, Trost D, Leenders F, Claude JC, Theuring F, Bargou R, Dietel M (2005) YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 65:4078–4087